Axinn Retains Top Rankings in LMG Life Sciences 2025
October 3, 2025
Axinn is pleased to announce that LMG Life Sciences has once again recognized the firm and its attorneys among the industry’s leaders for 2025. Partners Matt Becker and Aziz Burgy were named Life Sciences Stars, highlighting their continued excellence and impact in the field. Associate Ricardo Camposanto also retained his Rising Star designation, affirming his status as one of the industry’s emerging leaders.
This year, LMG Life Sciences ranked Axinn in Tier 2 for Hatch-Waxman Patent Litigation (Generic), underscoring the firm’s strength and experience in handling complex pharmaceutical patent cases.
LMG Life Sciences is the only legal ranking directory dedicated to identifying the top firms and lawyers across the life sciences sector.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
DC Bar: The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead
Speaking Engagement
Antitrust
Informa Antitrust Midwest 2026
Speaking Engagement
Antitrust
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2026
Sponsorship
What’s Up? Enforcement Updates From the Middle East and Africa
Podcast
Antitrust
AHLA Annual Meeting & In-House Counsel Program
Sponsorship
Antitrust
Lexology In-Depth: Intellectual Property and Antitrust (2026)
Byline Articles
Intellectual Property
Tracking The Rare 'Quick Look' Win In FTC's Zillow-Redfin Suit
Byline Articles
Antitrust
Gleiss Lutz Annual Antitrust Law Conference
Speaking Engagement
Antitrust
What Top Law Firms Say New Lawyers Need in the AI Era
Media Mentions
What’s the Role of Communications Strategy in M&A? How Public Affairs Impacts Antitrust
Podcast
Antitrust